Eyal Barad, CEO Cannabics Pharmaceuticals, talked with Rena Sherbill about the business side of the company, recent volatility in the stock, its investment in Seedo, its joint venture with Wize Pharma and the patents it has in development.
Learn more about your ad choices. Visit megaphone.fm/adchoices